PINE BROOK, N.J.–(BUSINESS WIRE)–Alvogen, today announced that it has acquired five hormonal branded
products from Bayer Pharma AG in Russia and CIS.
The products acquired are Klimonorm (Hormone replacement therapy),
Progynova (Hormone replacement therapy), Triquilar ( Female
contraception) and Microgynon (Female contraception) and Climene
(Hormone replacement therapy).
The acquisition of these well-established branded products further
strengthens and diversifies Alvogen’s branded portfolio in Central
Eastern Europe particularly in such a lucrative segment as Women
Healthcare. Alvogen has built a solid growth platform across the region,
with a presence in 11 markets including Russia and CIS, Romania,
Hungary, Bulgaria, Ukraine and the West Balkans. This presence is
supported by Alvogen’s strong manufacturing facilities in Romania and a
packaging center in Serbia, serving the entire region.
Commenting on the transaction, Petar Vazharov, EVP of Sales in the
CEE Region, said: “The acquisition of these products further
strengthens our local portfolio and enhances our platform for continued
growth across the region. CEE remains one of the most attractive regions
for our business, representing over 20% of Alvogen’s revenues, and we
continue to build our offer in this market to catalyze growth.”
Alvogen today has a commercial presence in 35 countries, with 200
projects in development, and is committed to becoming a leading global
generic pharmaceuticals player. Its three key operating regions are
North America, Asia Pacific and CEE.
Alvogen is a global, privately owned pharmaceutical company focused on
developing, manufacturing and selling generic, brand, over-the-counter
brands (OTC) and biosimilar products for patients around the world.
The company has commercial operations in 35 countries with 2,300
employees and operates four manufacturing and development hubs in the
US, Romania, Korea and Taiwan. North America is Alvogen’s single largest
market and other key markets include: South Korea, the West Balkans,
Poland, Romania, Bulgaria, Hungary, Taiwan, Thailand, Ukraine, Russia,
Japan and China.
Global Corporate Marketing &
(+354) 522 2900